Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

In vivo measurement of tumor estradiol and vascular endothelial growth factor in breast cancer patients.

Garvin S, Dabrosin C.

BMC Cancer. 2008 Mar 18;8:73. doi: 10.1186/1471-2407-8-73.

3.
5.
6.

Higher plasma vascular endothelial growth factor levels correlate with menopause, overexpression of p53, and recurrence of breast cancer.

Nishimura R, Nagao K, Miyayama H, Matsuda M, Baba K, Yamashita H, Fukuda M.

Breast Cancer. 2003;10(2):120-8.

PMID:
12736564
7.

Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.

Xu X, Wang B, Ye C, Yao C, Lin Y, Huang X, Zhang Y, Wang S.

Cancer Lett. 2008 Mar 18;261(2):147-57. doi: 10.1016/j.canlet.2007.11.028. Epub 2008 Jan 2.

PMID:
18171602
8.
9.

Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.

Dadiani M, Seger D, Kreizman T, Badikhi D, Margalit R, Eilam R, Degani H.

Endocr Relat Cancer. 2009 Sep;16(3):819-34. doi: 10.1677/ERC-08-0249. Epub 2009 Apr 27.

PMID:
19398483
10.

Estradiol increases VEGF in human breast studied by whole-tissue culture.

Garvin S, Nilsson UW, Huss FR, Kratz G, Dabrosin C.

Cell Tissue Res. 2006 Aug;325(2):245-51. Epub 2006 Mar 28.

PMID:
16568303
11.

Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer.

Iovino F, Ferraraccio F, Orditura M, Antoniol G, Morgillo F, Cascone T, Diadema MR, Aurilio G, Santabarbara G, Ruggiero R, Belli C, Irlandese E, Fasano M, Ciardiello F, Procaccini E, Lo Schiavo F, Catalano G, De Vita F.

Cancer Invest. 2008 Apr-May;26(3):250-5. doi: 10.1080/07357900701560612.

PMID:
18317965
13.

[Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance].

Wang XB, Yang QX, Pei XJ.

Nan Fang Yi Ke Da Xue Xue Bao. 2006 Jun;26(6):860-3. Chinese.

PMID:
16793622
14.

The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis.

Hormbrey E, Han C, Roberts A, McGrouther DA, Harris AL.

Clin Cancer Res. 2003 Oct 1;9(12):4332-9.

15.

The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.

Lowery AJ, Sweeney KJ, Molloy AP, Hennessy E, Curran C, Kerin MJ.

BMC Cancer. 2008 Sep 30;8:279. doi: 10.1186/1471-2407-8-279.

16.

[Vascular endothelial growth factor and two types of its receptors in breast cancer].

Shcherbakov AM, Gershteĭn ES, Anurova OA, Kushlinskiĭ NE.

Vopr Onkol. 2005;51(3):317-21. Russian.

PMID:
16279095
17.

[Expression of vascular endothelial growth factor in different breast tissues and clinical significance thereof].

Xu WG, Wang G, Liu Y, Zou YH, Song JN, Yang XQ, Wang WY.

Zhonghua Yi Xue Za Zhi. 2008 Mar 25;88(12):802-4. Chinese.

PMID:
18756980
18.

[Expressions of vascular endothelial growth factor and nm23-H1 gene and their relation to the prognosis of breast cancer in young women].

Huang ZH, Su GQ, Mao QG, Wang QZ, Li Z, Yu JL, Fan YF.

Di Yi Jun Yi Da Xue Xue Bao. 2004 Dec;24(12):1398-401. Chinese.

19.

Sex-steroid regulation of vascular endothelial growth factor in breast cancer.

Hyder SM.

Endocr Relat Cancer. 2006 Sep;13(3):667-87. Review.

PMID:
16954424
20.

Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.

Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, Henriksson R, Chen B, Pamula J, Pekala W, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B, Hallmans G, Försti A.

Clin Cancer Res. 2005 May 15;11(10):3647-53.

Supplemental Content

Support Center